{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:46:39Z","timestamp":1775760399763,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175045"],"award-info":[{"award-number":["175045"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.lfs.2018.10.059","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T02:06:45Z","timestamp":1540606005000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-5978","authenticated-orcid":false,"given":"Uro\u0161","family":"Pecikoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Micov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Tomi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radica","family":"Stepanovi\u0107-Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.10.059_bb0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/JPR.S37593","article-title":"Orofacial pain management: current perspectives","volume":"7","author":"Romero-Reyes","year":"2014","journal-title":"J. Pain Res."},{"key":"10.1016\/j.lfs.2018.10.059_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385198-7.00007-2","article-title":"Peripheral and central mechanisms of orofacial inflammatory pain","volume":"97","author":"Sessle","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2018.10.059_bb0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.lfs.2018.10.059_bb0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2018.10.059_bb0025","series-title":"Wall and Melzack's Textbook of Pain","first-page":"500","article-title":"Anticonvulsants: clinical","author":"Ali","year":"2013"},{"issue":"7","key":"10.1016\/j.lfs.2018.10.059_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-017-0441-0","article-title":"Sodium channel blockers in the treatment of epilepsy","volume":"31","author":"Brodie","year":"2017","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.lfs.2018.10.059_bb0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40265-016-0570-7","article-title":"Eslicarbazepine acetate monotherapy: a review in partial-onset seizures","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lfs.2018.10.059_bb0040","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1213\/ANE.0000000000000953","article-title":"The efficacy of eslicarbazepine acetate in models of trigeminal, neuropathic, and visceral pain: the involvement of 5-HT1B\/1D serotonergic and CB1\/CB2 cannabinoid receptors","volume":"121","author":"Tomi\u0107","year":"2015","journal-title":"Anesth. Analg."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.059_bb0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","article-title":"American Academy of Neurology Society; European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management","volume":"15","author":"Cruccu","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.lfs.2018.10.059_bb0050","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ejp.1192","article-title":"Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia","volume":"22","author":"Sanchez-Larsen","year":"2018","journal-title":"Eur. J. Pain"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.10.059_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014814924965","article-title":"Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024","volume":"27","author":"Ambr\u00f3sio","year":"2002","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.059_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.124","article-title":"Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action","volume":"3","author":"Soares-da-Silva","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.lfs.2018.10.059_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2018.06.002","article-title":"Antiepileptic drugs as analgesics\/adjuvants in inflammatory pain: current preclinical evidence","author":"Tomi\u0107","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.059_bb0070","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00965147","article-title":"Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine","volume":"19","author":"Baf","year":"1994","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.059_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2005.07.049","article-title":"Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11\u2011dihydro\u201110\u2011hydroxycarbamazepine","volume":"390","author":"Clinckers","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.059_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(83)90369-2","article-title":"The action of anticonvulsant drugs on the firing of locus coeruleus neurons: selective, activating effect of carbamazepine","volume":"91","author":"Olpe","year":"1983","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2018.10.059_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(00)00129-7","article-title":"Effects of carbamazepine on acetylcholine release and metabolism","volume":"40","author":"Mizuno","year":"2000","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.059_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0920-1211(02)00015-3","article-title":"Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex","volume":"49","author":"Zhu","year":"2002","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.059_bb0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0278-5846(97)00186-3","article-title":"Stress-dependent antinociceptive effects of carbamazepine: a study in stressed and nonstressed rats","volume":"22","author":"Mashimoto","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.10.059_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pain.2003.09.022","article-title":"Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron","volume":"107","author":"Dussor","year":"2004","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.059_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2006.10.041","article-title":"Noradrenaline inhibits substantia gelatinosa neurons in mice trigeminal subnucleus caudalis via alpha(2) and beta adrenoceptors","volume":"411","author":"Han","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2018.10.059_bb0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuropharm.2013.07.030","article-title":"Cholinergic modulation of primary afferent glutamatergic transmission in rat medullary dorsal horn neurons","volume":"75","author":"Jeong","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.10.059_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3959(01)00464-X","article-title":"Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat","volume":"98","author":"Wang","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2018.10.059_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuroscience.2013.01.016","article-title":"Central \u03b1\u2011adrenoceptors contribute to mustard oil-induced central sensitization in the rat medullary dorsal horn","volume":"236","author":"Wang","year":"2013","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.lfs.2018.10.059_bb0125","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpain.2006.04.010","article-title":"The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception","volume":"7","author":"Luccarini","year":"2006","journal-title":"J. Pain"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.059_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/000000003783992982","article-title":"The formalin test: characteristics and usefulness of the model","volume":"7","author":"Sawynok","year":"2003","journal-title":"Rev. Analg."},{"key":"10.1016\/j.lfs.2018.10.059_bb0135","series-title":"Drug Synergism and Dose-effect Data Analysis","author":"Tallarida","year":"2000"},{"issue":"5","key":"10.1016\/j.lfs.2018.10.059_bb0140","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1213\/01.ane.0000287270.35176.3e","article-title":"The involvement of peripheral alpha 2\u2011adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain","volume":"105","author":"Tomi\u0107","year":"2007","journal-title":"Anesth. Analg."},{"issue":"10","key":"10.1016\/j.lfs.2018.10.059_bb0145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1358\/mf.2007.29.10.1147773","article-title":"Role of alpha2\u2011adrenoceptors in the local peripheral antinociception by carbamazepine in a rat model of inflammatory mechanical hyperalgesia","volume":"29","author":"Vu\u010dkovi\u0107","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2018.10.059_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(83)90135-8","article-title":"Specific and potent interactions of carbamazepine with brain adenosine receptors","volume":"93","author":"Marangos","year":"1983","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2018.10.059_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0028-3908(84)90143-6","article-title":"Neurotransmitter-blocking agents influence antinociceptive effects of carbamazepine, baclofen, pentazocine and morphine on bradykinin-induced trigeminal pain","volume":"23","author":"Foong","year":"1984","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.10.059_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pain.2006.04.023","article-title":"The effects of alpha2\u2011adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain","volume":"125","author":"Vu\u010dkovi\u0107","year":"2006","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.059_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/157015908785777229","article-title":"Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation","volume":"6","author":"Samuels","year":"2008","journal-title":"Curr. Neuropharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2018.10.059_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2003.09.023","article-title":"Coeruleotrigeminal inhibition of nociceptive processing in the rat trigeminal subnucleus caudalis","volume":"993","author":"Tsuruoka","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2018.10.059_bb0175","series-title":"Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management","first-page":"275","article-title":"Adrenergic receptors","author":"Pertovaara","year":"2009"},{"issue":"7","key":"10.1016\/j.lfs.2018.10.059_bb0180","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjp.0705724","article-title":"Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats","volume":"141","author":"Chichorro","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.lfs.2018.10.059_bb0185","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/j.1532-2149.2012.00132.x","article-title":"Blockade of \u03b21-, \u03b22- and \u03b23-adrenoceptors in the temporomandibular joint induces antinociception especially in female rats","volume":"16","author":"F\u00e1varo-Moreira","year":"2012","journal-title":"Eur. J. Pain"},{"issue":"3","key":"10.1016\/j.lfs.2018.10.059_bb0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1358\/mf.2007.29.3.1075352","article-title":"Opioidergic mechanisms are not involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine","volume":"29","author":"Stepanovi\u0107-Petrovi\u0107","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2018.10.059_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1476-5381.1984.tb16512.x","article-title":"The periaqueductal gray is the site of the antinociceptive action of carbamazepine as related to bradykinin-induced trigeminal pain","volume":"83","author":"Foong","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.10.059_bb0200","series-title":"Wall and Melzack's Textbook of Pain","first-page":"129","article-title":"Central nervous system mechanisms of pain modulation","author":"Heinricher","year":"2013"},{"issue":"2","key":"10.1016\/j.lfs.2018.10.059_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/jn.1981.45.2.193","volume":"45","author":"Sessle","year":"1981","journal-title":"J. Neurophysiol."},{"issue":"37","key":"10.1016\/j.lfs.2018.10.059_bb0210","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1523\/JNEUROSCI.0943-13.2013","article-title":"Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and \u201ctriptan\u201d receptors: implications in migraine","volume":"33","author":"Akerman","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2018.10.059_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-4-54","article-title":"Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey","volume":"4","author":"Jeong","year":"2008","journal-title":"Mol. Pain"},{"issue":"5","key":"10.1016\/j.lfs.2018.10.059_bb0220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbi.2009.10.013","article-title":"Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain\u2014basic and therapeutic aspects","volume":"24","author":"Busch-Dienstfertig","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.lfs.2018.10.059_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1460-9568.2004.03459.x","article-title":"Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue","volume":"20","author":"Binder","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.lfs.2018.10.059_bb0230","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1073\/pnas.0409888102","article-title":"CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids","volume":"102","author":"Ibrahim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2018.10.059_bb0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(88)90296-8","article-title":"Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances","volume":"146","author":"Nakamura","year":"1988","journal-title":"Eur. J. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518306933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518306933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:17:26Z","timestamp":1758399446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518306933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":47,"alternative-id":["S0024320518306933"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.10.059","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eslicarbazepine acetate reduces trigeminal nociception: Possible role of adrenergic, cholinergic and opioid receptors","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.10.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}